email us   |      site map



Building Services

Commercial Developments



Energy and Renewables


Health and Safety



Industrial Pharma

Leisure and Amenity

Marine and Coastal

Project Management


Remedial Works

Roads and Bridges

Temporary Works

Traffic and Transportation

Water Services

industrial pharma

The development of major pharmaceutical projects in Cork Harbour have allowed Malachy Walsh and Partners to develop specialist skills in this market. For many years, the Practice has carried out a variety of projects for GlaxoSmithKline. In recent times, Malachy Walsh and Partners have also carried out significant development for Pfizer (Irl) Pharmaceuticals, BMS and more recently Amgen.

On these projects, the firm deals with all civil and structural issues including responsibility for obtaining Planning Permissions and Fire Certificates, Environmental Reviews, Traffic and Transportation Studies and Interpretative Geotechnical Reports.

Malachy Walsh and Partners are familiar with the very high level of specialist detail required by these projects. Specialist expertise include, clean rooms, production/process areas, laboratories, floor finishes, damage limiting construction, modular racks, etc.

The Practice has also developed capabilities in other elements of industrial development. A variety of successful projects have been completed for Heineken Ireland and Beamish and Crawford at their Cork Plants. In addition, Malachy Walsh and Partners have been involved in many of the upgrading and maintenance projects carried out at the ConocoPhillips Whitegate Refinery at Whitegate, Co. Cork.

Project: Department and Physical Properties Laboratory
Client: GlaxoSmithKline
Cost: €5million
Completion Date: January 2004

Project: Operations Building ‘Kaizen Centre’
Client: GlaxoSmithKline
Cost: €8million
Completion Date: August 2004

Project: Pfizer Security Buildings
Client: Pfizer (Irl) Pharmaceutical
Cost: €5million
Completion Date: 2002

Project: Pfizer Spray Dryer Facility
Client: Pfizer (Irl) Pharmaceutical
Cost: €90million
Completion Date: 2005

Project: Production Building 3, Module 2
Client: GlaxoSmithKline
Cost: €76million
Completion Date: February 2008



     Copyright © Malachy Walsh and Partners 2008 privacy policy | disclaimer